| Time | Congress Hall / Texas Ballroom A | Parallel 1 / Texas Ballroom Hall F | Parallel 2 / Texas Ballroom Hall H |
|---|---|---|---|
| 12:00 – 13:00 | .. | ||
| 13:00 – 13:30 | . | . | . |
| 13:30 – 17:00 | |||
17:00 – 18:30 | OPENING CEREMONY | . | . |
| 17:00 – 17:05 | Introduction Paul Mansfield (U.S.A.) | ||
| 17:05 – 17:15 | Welcoming comments Peter Pisters (U.S.A.) | . | . |
| 17:15 – 17:45 | Checkpoint blockade in solid tumors | ||
| 17:45 – 18:15 | Space medicine Robert Satcher (U.S.A.) | . | . |
| 18:15 – 18:30 | Q&A | . | .. |
18:30 – 20:00 | WELCOME RECEPTION |
| Time | Congress Hall / Texas Ballroom A | Parallel 1 / Texas Ballroom Hall F | Parallel 2 / Texas Ballroom Hall H | ||
|---|---|---|---|---|---|
| 7:30 – 8:00 | COFFEE | ||||
8:00 – 9:30 | Scientific Session (S/P): Highlights of gastric cancer progress Co-Moderators: Giovanni deManzoni (Italy) & Jorge Gallardo (Chile) | Scientific Session (P/M): Molecular and pathology classifications Co-Moderators: Florian Lordick (Germany) & Heike Grabsch (The Netherlands) | Workshop (S): Proximal gastrectomy | ||
| 8:05 – 8:25 | Overview of what is new in surgery | Pathology classification of gastric cancer: an overview | Laparoscopic proximal gastrectomy with double-flap reconstruction | ||
| 8:25 – 8:45 | Overview of what is new in radiotherapy | Molecular profiles of stomach cancer at the Single-cell level Patrick Tan (Singapore) | Robotic proximal gastrectomy and intramediastinal anastomosis | ||
| 8:45 – 9:05 | Overview of what is new in medical oncology | Clinical relevance of gene signature based molecular classification of gastric cancer | PG with double-tract reconstruction; results of KLASS-5 trial | ||
| 9:05 – 9:20 | Lessons on Developing International and Interdisciplinary Collaborations Giovanni de Manzoni (Italy) | Does mucinous gastric cancer deserve a special approach? | The CARDIA-trial results – Ivor-Louis esophagectomy vs. total gastrectomy for Siewert Type II tumors | ||
| 9:20 – 9:25 | Lessons on Developing International and Interdisciplinary Collaborations Giovanni de Manzoni (Italy) | Discussion | The CARDIA-trial results – Ivor-Louis esophagectomy vs. total gastrectomy for Siewert Type II tumors | ||
| 9:25 – 9:30 | Discussion | Discussion | Discussion | ||
| 9:30 – 10:00 | BREAK | ||||
10:00 – 12:00 | Plenary Session Co-Moderators: Osvaldo Castro (Brazil) & Han-Kwang Yang (Republic of South Korea) | . | . | ||
| 10:00 – 10:15 | Presidential Lecture Paul Mansfield (U.S.A.) | ||||
| 10:15 – 10:25 | Laparoscopic Proximal Vs. Total Gastrectomy For Upper Third Egc: Klass-05 Randomized Clinical Trial | ||||
| 10:25 – 10:35 | Chronological Improvement In The Survival Of Advanced Gastric Cancer Patients In The Past 15 Years | ||||
| 10:35 – 10:45 | National Cancer Screening Program For Gastric Cancer In Korea: Nationwide Treatment Benefit And Cost | ||||
| 10:45 – 10:55 | Genotype-Phenotype Associations Provide A Rational To Identify Potentially Actionable Vus | ||||
| 10:55 – 11:05 | Microsatellite Instability And Sex Differences In Resectable Gc – A European Multicenter Study Hedde Biesma (The Netherlands) | ||||
| 11:05 – 11:15 | Fam46c/Tent5c Expression Predicts Post-Resection Survival And Suppresses Gastric Cancer Progression | ||||
| 11:15 – 11:25 | Clinically Conserved Subtypes From Meta-Analysis Of Genomic Data From Human Gastric Cancer | ||||
| 11:25 – 12:00 | Discussion | ||||
| 12:00 – 13:00 | LUNCH BREAK | Industry Symposium | |||
13:00 – 14:30 | Scientific Session (S/M): Surgery and perioperative treatment for GEJ tumors Co-Moderators: Wayne Hofstetter (U.S.A.) & Marcus Kodama Ramos (Brazil) | Scientific Session (M): Targeted therapy for gastric cancer Co-Moderators: Josep Tabernero (Spain) & Ryan Huey (U.S.A.) | Scientific Session (S): CDH1 & Gastric cancer genetics Co-Moderators: Carla Oliveira (Portugal) & Parry Guilford (New Zealand) | ||
| 13:05 – 13:25 | Multimodality therapy for GEJ tumors – where are we now and what is on the horizon | Pathology – heterogeneity of targeted expression Nicole van Grieken (The Netherlands) | Genotype-Phenotype associations in CDH1 pathogenic and likely pathogenic variant carrier families Carla Oliveira (Portugal) | ||
| 13:25 – 13:30 | Role of radiation therapy for GEJ tumors | Pathology – heterogeneity of targeted expression Nicole van Grieken (The Netherlands) | Genotype-Phenotype associations in CDH1 pathogenic and likely pathogenic variant carrier families Carla Oliveira (Portugal) | ||
| 13:30 – 13:45 | Role of radiation therapy for GEJ tumors | Her2 targeted therapy | Gut Hormones and Functional Recovery after PTG | ||
| 13:45 – 13:55 | Surgical approach for GEJ tumors | Her2 targeted therapy | Association between hereditary lobular breast cancer due to CDH1 variants and gastric cancer risk Jeremy Davis (U.S.A.) | ||
| 13:55 – 14:05 | Surgical approach for GEJ tumors | Targeted therapy beyond HER2: FGFR2, MET, Claudin18.2 Josep Tabernero (Spain) | Association between hereditary lobular breast cancer due to CDH1 variants and gastric cancer risk Jeremy Davis (U.S.A.) | ||
| 14:05 – 14:15 | Thoracophrenolaparomy For Surgical Treatment Of Gastro Esophageal Junction Cancer Giovanni Maria Garbarino (The Netherlands) | Targeted therapy beyond HER2: FGFR2, MET, Claudin18.2 Josep Tabernero (Spain) | Synthetic lethality: a promise for the treatment of hereditary diffuse gastric cancer Parry Guilford (New Zealand) | ||
| 14:15 – 14:20 | Differences In Pathology Between Adenocarcinoma Of Lower Esophagus And Gastro-Esophageal Junction | Targeted therapy beyond HER2: FGFR2, MET, Claudin18.2 Josep Tabernero (Spain) | Synthetic lethality: a promise for the treatment of hereditary diffuse gastric cancer Parry Guilford (New Zealand) | ||
| 14:20 – 14:25 | Differences In Pathology Between Adenocarcinoma Of Lower Esophagus And Gastro-Esophageal Junction | Discussion | Synthetic lethality: a promise for the treatment of hereditary diffuse gastric cancer Parry Guilford (New Zealand) | ||
| 14:25 – 14:30 | Discussion | Discussion | Discussion | ||
| 14:30 – 15:00 | BREAK | ||||
15:00 – 16:30 | Great Debates (R/S) | Scientific Session (M): Immunotherapy for gastric cancer Co-Moderators: Jaffer Ajani (U.S.A.) & Kei Muro (Japan) | Top-rated surgical videos (S) Co-Moderators: Yasuhiro Kodera (Japan) & Yanghee Woo (U.S.A.) Video sessions | ||
| 15:00 – 15:05 | Debate #1: Does radiation therapy work in gastric cancer?
| Better survival after fluorescent lymphography guided lymphadenectomy for gastric cancer Sung Hyun Park (Republic of South Korea) | |||
| 15:05 – 15:15 | Debate #1: Does radiation therapy work in gastric cancer?
| Challenges in patient selection for immunotherapy – testing Jeannelyn Estrella (U.S.A.) | Better survival after fluorescent lymphography guided lymphadenectomy for gastric cancer Sung Hyun Park (Republic of South Korea) | ||
| 15:15 – 15:20 | Debate #1: Does radiation therapy work in gastric cancer?
| Challenges in patient selection for immunotherapy – testing Jeannelyn Estrella (U.S.A.) | Long-term quality of life and nutritional results after sentinel node navigation surgery Bang Wool Eom (Republic of South Korea) | ||
| 15:20 – 15:25 | Debate #1: Does radiation therapy work in gastric cancer?
| Immunotherapy for localized disease Yelena Janjigian (U.S.A.) | Long-term quality of life and nutritional results after sentinel node navigation surgery Bang Wool Eom (Republic of South Korea) | ||
| 15:25 – 15:32 | Debate #1: Does radiation therapy work in gastric cancer?
| Immunotherapy for localized disease Yelena Janjigian (U.S.A.) | Double-loop intracorporeal reconstruction after robotic total gastrectomy for gastric cancer Domenico Di Nardo (Italy) | ||
| 15:32 – 15:40 | Debate #1: Does radiation therapy work in gastric cancer?
| Immunotherapy for localized disease Yelena Janjigian (U.S.A.) | Laparoscopic splenic hilar lymphadenectomy for advanced gastric cancer Long Duy Vo (Vietnam) | ||
| 15:40 – 15:45 | Debate #1: Does radiation therapy work in gastric cancer?
| Immunotherapy for metastatic disease Kohei Shitara (Japan) | Mediastinoscopic Ivor-Lewis esophagectomy for esophagogastric junction adenocarcinoma Akihiro Suzuki (Japan) | ||
| 15:45 – 15:53 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Immunotherapy for metastatic disease Kohei Shitara (Japan) | Reduced-ports distal gastrectomy using laparoscopic articulating devices for advanced gastric cancer So Hyun Kang (Republic of South Korea) | ||
| 15:53 – 16:00 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Immunotherapy for metastatic disease Kohei Shitara (Japan) | Totally laparoscopic mesogastrectomy with delta-shaped anastomosis for posterior wall schwannoma Lorenzo Ferri (Italy) | ||
| 16:00 – 16:07 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Targeting Hippo/YAP1 as a novel therapeutic strategy in Gastric adenocarcinoma with Peritoneal Metastases Shumei Song (U.S.A.) | Technical challenges in a robotic total gastrectomy Taleen MacArthur (U.S.A.) | ||
| 16:07 – 16:15 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Targeting Hippo/YAP1 as a novel therapeutic strategy in Gastric adenocarcinoma with Peritoneal Metastases Shumei Song (U.S.A.) | Laparoscopic proximal gastrectomy with double-flap reconstruction for tumors in 1/3 upper of stomach Long Duy Vo (Vietnam) | ||
| 16:15 – 16:20 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Targeting Hippo/YAP1 as a novel therapeutic strategy in Gastric adenocarcinoma with Peritoneal Metastases Shumei Song (U.S.A.) | Single-port intragastric wedge resection using the tunnel method So Hyun Kang (Republic of South Korea) | ||
| 16:20 – 16:25 | Debate #2: Is sentinel node mapping indicated in gastric cancer?
| Discussion | Discussion | ||
| 16:25 – 16:30 | Discussion | Discussion | Discussion | ||
16:30 – 17:00 | JP Kim Lecture
| . | – | ||
16:35 – 17:00 | Neoadjuvant Therapy for Gastric Cancer: Toward Personalized Medicine | ||||
17:00 – 18:00 | Poster Grand Round Co-Moderators: Allison Martin (U.S.A.) & Derek Erstad (U.S.A.) | , | . | ||
| Time | Congress Hall / Texas Ballroom A | Parallel 1 / Texas Ballroom Hall F | Parallel 2 / Texas Ballroom Hall H | ||
|---|---|---|---|---|---|
8:00 – 9:30 | Scientific Session (S/GI): Robotic, Laparoscopic & Endoscopic Surgery Co-Moderators: Miguel Burch (U.S.A.) & Sang-Uk Han (Republic of South Korea) | Scientific Session (M): Liquid biopsy and tumor profiling in gastric cancer Co-Moderators: Adam Bass (U.S.A.) & Satoru Matsuda (Japan) | Workshop (S): ERAS protocol after gastrectomy | ||
| 8:05 – 8:25 | Laparoscopic Gastrectomy – Japanese experience and future prospective | Serum miRNA in early gastric cancer detection/screening Jimmy So (Singapore) | ERAS principles – Anesthesia perspective Vijaya Gottumukkala (U.S.A.) | ||
| 8:25 – 8:45 | UGIRA experience of robotic gastrectomy education/registry | ctDNA applications in non-metastatic gastric cancer Sam Klempner (U.S.A.) | Regional differences in ERAS – Asian perspective Do Joong Park (Republic of South Korea) | ||
| 8:45 – 9:05 | Education/learning curve of robotic gastrectomy | ctDNA applications in advanced disease: Biomarker testing, monitoring, resistance Elizabeth Smyth (U.S.A.) | Issues specific to gastrectomy Jacopo Weindelmayer (Italy) | ||
| 9:05 – 9:15 | Extended indication for endomucosal resection for gastric cancer | Multi-omic profiling to explore heterogeneity in gastric cancer Yosuke Tanaka (Japan) | Minimally Invasive Recovery Program In The Era Of Minimally Invasive Gastrectomy For Gastric Cancer | ||
| 9:15 – 9:25 | Extended indication for endomucosal resection for gastric cancer | Multi-omic profiling to explore heterogeneity in gastric cancer Yosuke Tanaka (Japan) | Discussion | ||
| 9:25 – 9:30 | Discussion | Discussion | Discussion | ||
| 9:30 – 10:00 | BREAK | ||||
10:00 – 12:00 | Plenary Session (All): International updates of gastric cancer treatment | . | Workshop (S): Supportive & palliative care | ||
| 10:05 – 10:20 | Updates from Korea Han-Kwang Yang (Republic of South Korea) | , | Supportive care overview, benefits of interdisciplinary care Elizabeth Lilley (U.S.A.) | ||
| 10:20 – 10:25 | Updates from North America Carol Swallow (Canada) | , | Supportive care overview, benefits of interdisciplinary care Elizabeth Lilley (U.S.A.) | ||
| 10:25 – 10:35 | Updates from North America Carol Swallow (Canada) | Palliative radiation for symptomatic primary and metastatic gastric cancer Emma Holliday (U.S.A.) | |||
| 10:35 – 10:45 | Updates from South America Bruno Zilberstein (Brazil) | Palliative radiation for symptomatic primary and metastatic gastric cancer Emma Holliday (U.S.A.) | |||
| 10:45 – 10:50 | Updates from South America Bruno Zilberstein (Brazil) | . | Palliative Gastroenterology Kalpesh Patel (U.S.A.) | ||
| 10:50 – 11:05 | Updates from Japan Masanori Terashima (Japan) | Palliative Gastroenterology Kalpesh Patel (U.S.A.) | |||
| 11:05 – 11:20 | Updates from China Xiaotian Zhang (China) | . | Palliative Surgery Bridget Fahy (U.S.A.) | ||
| 11:20 – 11:25 | Updates from Europe Domineco D’Ugo (Italy) | Palliative Surgery Bridget Fahy (U.S.A.) | |||
| 11:25 – 11:35 | Updates from Europe Domineco D’Ugo (Italy) | Discussion & cases | |||
| 11:35 – 12:00 | Discussion | . | Discussion & cases | ||
| 12:00 – 13:00 | LUNCH BREAK | ||||
13:00 – 14:30 | Scientific Session (S): Peritoneal directed therapy Co-Moderators: Travis Grotz (U.S.A.) & Santiago Gonzalez-Moreno (Spain) | Scientific Session (M): Microbiome and H. Pylori Co-Moderators: Jennifer Wargo (U.S.A.) & Nadim Ajami (U.S.A.) | Workshop (M/S): What is the next study we should do? Big questions in the field | ||
| 13:05 – 13:20 | HIPEC Johanna van Sandick (The Netherlands) |
| Phase I studies for gastric cancer David Hong (U.S.A.) | ||
| 13:20 – 13:25 | HIPEC Johanna van Sandick (The Netherlands) | The Microbiome in gastric cancer Ceu Figueiredo (Portugal) | Phase I studies for gastric cancer David Hong (U.S.A.) | ||
| 13:25 – 13:35 | IP Paclitaxel Hironori Ishigami (Japan) | The Microbiome in gastric cancer Ceu Figueiredo (Portugal) | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 13:35 – 13:45 | IP Paclitaxel Hironori Ishigami (Japan) | H. Pylori and gastric cancer David Graham (U.S.A) | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 13:45 – 13:50 | PIPAC Mohammad Alyami (Saudi Arabia) | H. Pylori and gastric cancer David Graham (U.S.A) | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 13:50 – 14:05 | PIPAC Mohammad Alyami (Saudi Arabia) | Dietary constituents that augment the ability of H. pylori to cause cancer? Richard Peek, (U.S.A.) | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 14:05 – 14:20 | Discussion & cases | A novel animal model to study the role of microbiome in gastric cancer Yong Chan Lee (Republic of South Korea) | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 14:20 – 14:25 | Discussion & cases | Discussion | Roundtable Discussion Mariela Blum Murphy (U.S.A.) Suzanne Gisbertz (The Netherlands) David Hong (U.S.A.) Geoffrey Ku (U.S.A.) Zev Wainburg (U.S.A.) | ||
| 14:25 – 14:30 | Discussion & cases | Discussion | Session Wrap Mariela Blum Murphy (U.S.A.) David Hong (U.S.A.) | ||
| 14:30 – 15:00 | BREAK | ||||
15:00 – 16:30 | Great Debates (M) | Scientific Session (All): Artificial Intelligence in the management of gastric cancer | Patient-provider Workshop (S): Nutrition and PROs, QOL What about the gall bladder? (survivorship) Co-Moderators: Natalie Coburn (Canada) & Kaitlyn Kelly (U.S.A.) | ||
| 15:00 – 15:12 | Debate #1: (Neo) Adjuvant chemotherapy for MSI-high gastric cancer | Role of AI in gastric cancer pathology | Introduction – How should we measure outcomes? Bilal Alkhaffaf (UK) | ||
| 15:12 – 15:25 | Debate #1: (Neo) Adjuvant chemotherapy for MSI-high gastric cancer | Role of AI in gastric cancer pathology | Does construction of a pouch improve QOL? A systemic review Jimmy So (Singapore) | ||
| 15:25 – 15:36 | Debate #1: (Neo) Adjuvant chemotherapy for MSI-high gastric cancer | AI for designing drug Jens Meiler (Germany) | Bone health in the post-gastrectomy patients Theresa Guise (U.S.A.) | ||
| 15:36 – 15:45 | Debate #1: (Neo) Adjuvant chemotherapy for MSI-high gastric cancer | AI for designing drug Jens Meiler (Germany) | Management of iron deficiency, B12 Kaitlyn Kelly (U.S.A.) | ||
| 15:45 – 16:00 | Debate #2: Chemotherapy + Immunotherapy for all metastatic gastric cancer | AI for endoscopic diagnosis | Advocacy Groups, how they can make your and your patients’ lives better Jeff Netzer (U.S.A.) | ||
| 16:00 – 16:05 | Debate #2: Chemotherapy + Immunotherapy for all metastatic gastric cancer | AI for endoscopic diagnosis | Building the ideal team to support patients and improve outcomes Geoff Roberts (U.K) | ||
| 16:05 – 16:12 | Debate #2: Chemotherapy + Immunotherapy for all metastatic gastric cancer | AI imaging reconstruction to guide surgery | Building the ideal team to support patients and improve outcomes Geoff Roberts (U.K) | ||
| 16:12 – 16:25 | Debate #2: Chemotherapy + Immunotherapy for all metastatic gastric cancer | AI imaging reconstruction to guide surgery | Discussion | ||
| 16:25 – 16:30 | Discussion | Discussion | Discussion | ||
16:30 – 17:00 | Nishi Takahashi Lecture | , | , | ||
| 16:35 – 17:00 | Challenges in gastric cancer care across socio-economic spectrum Paulo Kassab (Brazil) | ||||
17:00 – 18:00 | Poster Grand Round Co-Moderators: Andrew Newton (U.S.A.) & Yuki Hirata (U.S.A.) | . | . | ||
| Time | Congress Hall / Texas Ballroom A | Parallel 1 / Texas Ballroom Hall F | Parallel 2 / Texas Ballroom Hall H |
|---|---|---|---|
8:00 – 9:30 | Video Surgery Master Class (S) Co-Moderators: Jae-Moon Bae (Republic of South Korea) & Koichi Suda (Japan) | Scientific Session(R): Hot topics in radiotherapy | Gastric Cancer Patient Symposium: The Role of Advocacy for the Gastric Cancer Community |
| 8:00 – 8:05 | Reduced-port robotic gastrectomy Hyoung-Il Kim (Republic of South Korea) | Adjuvant Chemotherapy Is Superior To Chemoradiation In The Critics Trial | Organization Overview: No Stomach for Cancer (U.S.A.) |
| 8:05 – 8:15 | Reduced-port robotic gastrectomy Hyoung-Il Kim (Republic of South Korea) | Emerging Role of Preoperative Chemoradiation Marcel Verheij (The Netherlands) | Organization Overview: No Stomach for Cancer (U.S.A.) |
| 8:15 – 8:20 | Reduced-port robotic gastrectomy Hyoung-Il Kim (Republic of South Korea) | Emerging Role of Preoperative Chemoradiation Marcel Verheij (The Netherlands) | Organization Overview: My Gut Feeling (Canada) |
| 8:20 – 8:25 | Reduced-port robotic gastrectomy Hyoung-Il Kim (Republic of South Korea) | Emerging Role of Preoperative Chemoradiation Marcel Verheij (The Netherlands) | Organization Overview: My Gut Feeling (Canada) |
| 8:25 – 8:30 | MIS esophagectomy for GEJ cancer Hon Chi Yip (China) | Radiation Therapy for Oligometastases of Gastric Cancer | Organization Overview: My Gut Feeling (Canada) |
| 8:30 – 8:35 | MIS esophagectomy for GEJ cancer Hon Chi Yip (China) | Radiation Therapy for Oligometastases of Gastric Cancer | Organization Overview: Debbie’s Dream Foundation (U.S.A.) |
| 8:35 – 8:45 | MIS esophagectomy for GEJ cancer Hon Chi Yip (China) | Radiation Therapy for Oligometastases of Gastric Cancer | Organization Overview: Debbie’s Dream Foundation (U.S.A.) |
| 8:45 – 8:50 | Intraoperative visualization of tissue perfusion in gastric surgery Victor Kashchenko (Russia) | Role of radiation therapy from Surgeon’s perspective | Organization Overview: Gastric Cancer Foundation (U.S.A.) |
| 8:50 – 9:00 | Intraoperative visualization of tissue perfusion in gastric surgery Victor Kashchenko (Russia) | Role of radiation therapy from Surgeon’s perspective | Organization Overview: Gastric Cancer Foundation (U.S.A.) |
| 9:00 – 9:05 | Intraoperative visualization of tissue perfusion in gastric surgery Victor Kashchenko (Russia) | Role of radiation therapy from Surgeon’s perspective | Organisation Overview: Vivere Sensa Stomaco si Puo (Italy) |
| 9:05 – 9:15 | Robotic assisted gastrectomy for advanced gastric cancer Masanori Tokunaga (Japan) | Proton Therapy for Esophageal and Gastro-esophageal cancers | Organisation Overview: Vivere Sensa Stomaco si Puo (Italy) |
| 9:15 – 9:20 | Robotic assisted gastrectomy for advanced gastric cancer Masanori Tokunaga (Japan) | Proton Therapy for Esophageal and Gastro-esophageal cancers | Organization Overview: Stupid Strong (U.S.A.) Jeff Netzer |
| 9:20 – 9:25 | Robotic assisted gastrectomy for advanced gastric cancer Masanori Tokunaga (Japan) | Proton Therapy for Esophageal and Gastro-esophageal cancers | Organization Overview: Stupid Strong (U.S.A.) Jeff Netzer |
| 9:25 – 9:30 | Discussion | Discussion | Organization Overview: Stupid Strong (U.S.A.) Jeff Netzer |
| 09:30 – 09:45 | BREAK | BREAK | Organization Overview: Hope for Stomach Cancer (U.S.A.) Aki Smith |
| 09:45 – 10:00 | BREAK | BREAK | BREAK |
10:00 – 12:00 | Plenary Session (All) | Scientific Session (GI/S): Early Detection, screening, and prevention of gastric cancer | Gastric Cancer Patient Symposium |
| 10:05 – 10:15 | Five-year outcomes of the Klass-02 randomized clinical trial: Ldg vs Odg for locally Agc Sang-Yong Son (Republic of South Korea) | Early detection/screening Joo Ha Hwang (U.S.A.) | Food Advocate/Chef |
| 10:15 – 10:25 | Cea targeted monoclonal antibody with Nir Fluorochrome for gastric cancer specific imaging Eunhee Koo (Republic of South Korea) | Early detection/screening Joo Ha Hwang (U.S.A.) | Nutrients and drug absorption and impact on pregnancy |
| 10:25 – 10:35 | Two decades of gastric cancer screening in western Honduras and the effects of Covid-19 outbreak Dalton Argean Norwood (U.S.A.) | Should we be screening high-risk groups for H. Pylori? | Mental Health / Wellbeing |
| 10:35 – 10:45 | Surgical skills affect the clinical outcomes in patients with locally advanced distal gastric cancer Jiao-Bao Huang (China) | Should we be screening high-risk groups for H. Pylori? | Conception, pregnancy and early motherhood post-PTG |
| 10:45 – 10:55 | Genomic landscape of targeted deep sequencing for advanced gastric cancer patients: K-Master project Yeul Hong Kim (Republic of South Korea) | New innovation tech – Cancer Seek Nickolas Papadopoulos (U.S.A.) | Nutrition after Gastrectomy |
| 10:55 – 11:05 | Association of tumor infiltrating T-Lymphocytes with survival in resectable gastric cancer Tanya Soeratram (The Netherlands) | New innovation tech – Cancer Seek Nickolas Papadopoulos (U.S.A.) | Nutrition after Gastrectomy |
| 11:05 – 11:15 | East-Asia and West-Europe survival disparities in early gastric cancer: Reasons and biomarkers Carla Pereira (Portugal) | Early research and next steps in early detection Samir Hanash (U.S.A.) | Psychosocial well-being after cancer |
| 11:15 – 11:25 | 5-Aminolevulinic acid for photodynamic diagnosis of peritoneal metastases due to gastric cancer Tsuyoshi Takahashi (Japan) | Early research and next steps in early detection Samir Hanash (U.S.A.) | Discussion & Q&A |
| 11:25 – 11:30 | Discussion | Discussion | Discussion & Q&A |
12:00 – 12:20 | GENERAL ASSEMBLY | . |
